newsfilter
← Latest News
GlobeNewswire·

VectivBio Announces Date of Extraordinary General Meeting of Shareholders

BASEL, Switzerland, Oct. 12, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG ("VectivBio") (NASDAQ:VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare